1Global tuberculosis control:surveillance planning financing. WHO report 2007[ R]. Geneva, World Health Organization ( WHO/HTM/TB/ 2007. 376 ).
2GAZDIK M A, McDONOUGH K A. Identification of cyclic AMP-regulated genes in Mycobacterium tuberculosis complex bacteria under lowoxygen conditions[ J ]. J Bacteriol,2005,4 ( 8 ) :2681-2692.
4SiINGH K K, DONG Y, PATIBANDLA S A,et al. Immunogenicity of the Mycobacterium tuberculosis PPE55 (Rv3347c) protein during incipient and clinical tuberculosis [ J ]. Infect Immun, 2005,8 ( 8 ) : 5004- 5014.
5SABLE S B, KUMAR R,KALRA M ,et al. Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in Human models of immunity to tuberculosis[J]. Infect Immun,2005,6(6) :3547-3558.
6MOLLENKOPF H J,GRODE L,MATTOW J,et al. Application of mycobacterial proteomics to vaccine design:improved protection by Mycobacterium boris BCG prime-Rv3407 DNA boost vaccination against tuberculosis[ J ]. Infect Immun ,2004,11 ( 11 ) :6471-6479.
8PHEIFFER C,BETTS J C,FLYNN H R,et al. Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv [ J ]. Microbiology, 2005,151 ( Pt4 ), 1139- 1150.
9MAWUENYEGA K G,FORST C V,DOBOS K M,et al. Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling[ J]. Molec Biol Cell ,2005,16( 1 ) :396-404.
10GU S,CHEN J, DOBOS K M, et al. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain [ J]. Molecular & Cellular Proteomics,2003,2(12) : 1284-1296.
二级参考文献27
1Molloy M P, Phadke N D, Maddock J R, et al. Two-dimensional electrophoresis and peptide mass fingerprinting of bacterial outer membrane proteins[J]. Electrophoresis. 2001,22(9) : 1686-1696.
2Herbert B. Advances in protein solubilisation for two-dimensional electrophoresis[J]. Electrophoresis. 1999, 20(4-5) : 660-663.
3William K L. Genomes and proteomes: Towards a multidimensional view of biology[J ]. Electrophoresis. 1999,20(4-5) :678-688.
4Kossen K, Uhlenbeck O C. Cloning and biochemical characterization of Bacillus subtilis YxiN, a DEAD protein specifically activated by 23S rRNA: Delineation of a novel sub-family of bacterial DEAD proteins[J]. Nucleic Acids Research. 1999, 27(19) : 3811-3820.
5Tanner N K, Linder P. DExD/H box RNA helicases: From generic motors to specific dissociation functions[J ].MOLECULAR CELL. 2001, 8(2) : 251-262.
6Grandori C, Mac J, Siebelt F, et al. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo[J]. Embo Journal. 1996, 15(16) : 4344-4357.
7郭尧君.蛋白质电泳实验技术[M].北京：科学出版社,2001..
8Hiraoka A,Sugimura A,Seki T,Nagasawa T,Ohta N,Shimonishi M,Hagiya M,Shimizu S.Cloning,expression,and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cells.Proc Natl Acad Sci USA,1997,94(14):7577 ～ 7582
9Mazzaccaro R J,Gedde M,Jensen E R,Santen H M,Ploegh H L,Rock K L,Bloom B R.Major histocompatibility class Ⅰ presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.Proc.Natl Acad Sci USA,1996,93(21):11786～ 11791
10Cho S,Mehra V,Thoma-Uszynski S,Stenger S,Serbina N,Mazzaccaro R J,Flynn J L,et al.Antimicrobial activity of MHC class l-restricted CD8 + T cells in human tuberculosis.Proc Natl Acad Sci USA.2000,97(22):12210～12215
1Christiansen MN, Chik J, Lee L, et al. Cell surface protein glyco- sylation in cancer [ J]1. Proteomics. 2013. doi: 10. 1002/pmic. 201300387. [ Epub ahead of print ].
2Narimatsu H. Construction of a library and comprehensive functional analysis[J]. Glycoconj J, 2004, 21(1-2) : 17-24.
3Lattova E, Tomanek B, Bartusik D, et al. N-glycomic changes in human breast arcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex [ J ]. J Proteome Res, 2010, 9(3): 1533-1540.
4Fiala R, Sulova Z, El-Saggan AH, et al. P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents[ J ]. Biochim Biophys Acta, 2003, 1639(3) : 213-224.
5Kudo T, Nakagawa H, Takahashi M, et al. N-glycan alternations are associated with drug resistance in human hepatocellular carcino- ma[J]. MolCancer, 2007, 6(1): 32-38.
6Breier A, Barancik M, Sulova Z, et al. P-glycoprotein simplica- tions of metabolism of neoplastic cells and cancer therapy [ J ]. Curr Cancer Drug Targets, 1995, 5(6) : 457-568.
7Kramer R, Weber TK, Arceci R, et al. Inhibition of N-linked gly- cosylation of P-glycoprotein by tunicamycin results in a reduced mul- tidrug resistance phenotype[J]. Br J Cancer, 1995, 71 (4) : 670- 675.
9Jia L, Xu H, Zhao Y, et al. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma [J]. Cancer Invest, 2008, 26: 977-983.
10Liu Z, Shen L, Xu L, et al. Down-regulation of β-1,3- N-acetyl- glueosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer[J]. Mol Med Report, 2011 , 4(3) : 497-503.
